Literature DB >> 3091895

Tissue-type plasminogen activator in breast cancer: relationship with estradiol and progesterone receptors.

M J Duffy, P O'Grady, J Simon, M Rose, H R Lijnen.   

Abstract

Plasminogen activator (PA) is an estradiol-inducible enzyme and therefore a potential marker for a functional estradiol receptor (ER) in human breast carcinomas. In this investigation tissue-type PA (t-PA) correlated significantly with both ER and progesterone receptors (PR) in human breast carcinomas. In contrast, neither total PA activity nor urokinase-like PA showed any significant correlation with either ER or PR. Other proteases such as a trypsin-like protease, a chymotrypsin-like protease, and cathepsin B also showed no correlation with ER and PR. It was concluded that the t-PA form of PA may be a marker for a functional ER in breast carcinoma and thus be of value in predicting hormone-dependent breast cancers.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091895     DOI: 10.1093/jnci/77.3.621

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  6 in total

Review 1.  The role of proteolytic enzymes in cancer invasion and metastasis.

Authors:  M J Duffy
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

2.  Proteinase-like peptidase activities and oestrogen receptor levels in breast cancer tissue.

Authors:  A Vasishta; P R Baker; P E Preece; R A Wood; A Cuschieri
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

3.  Inhibition of postconfluent focus production in cultures of MCF-7 human breast cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  J F Gierthy; D W Lincoln
Journal:  Breast Cancer Res Treat       Date:  1988-10       Impact factor: 4.872

4.  Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer.

Authors:  J H de Witte; C G Sweep; J G Klijn; N Grebenschikov; H A Peters; M P Look; T H van Tienoven; J J Heuvel; J Bolt-De Vries; T J Benraad; J A Foekens
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

5.  Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours.

Authors:  D Foucré; C Bouchet; K Hacène; N Pourreau-Schneider; A Gentile; P M Martin; A Desplaces; J Oglobine
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

6.  Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor.

Authors:  A S Levenson; H C Kwaan; K M Svoboda; I M Weiss; S Sakurai; V C Jordan
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.